Aardvark Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AARD and other ETFs, options, and stocks.About AARD
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases.
AARD Key Statistics
Stock Snapshot
As of today, Aardvark Therapeutics(AARD) shares are valued at $14.38. The company's market cap stands at 350.82M, with a P/E ratio of -6.42.
As of 2025-12-13, Aardvark Therapeutics(AARD) stock has fluctuated between $14.32 and $15.97. The current price stands at $14.38, placing the stock +0.4% above today's low and -10.0% off the high.
Aardvark Therapeutics(AARD) shares are trading with a volume of 267.18K, against a daily average of 282.55K.
During the past year, Aardvark Therapeutics(AARD) stock moved between $4.88 at its lowest and $19.58 at its peak.
During the past year, Aardvark Therapeutics(AARD) stock moved between $4.88 at its lowest and $19.58 at its peak.
AARD News
William Blair initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating. The firm says Aardvark is advancing ARD-101, an oral therapy that ta...
Aardvark Therapeutics (AARD) announced that the first patient has been dosed in Australia in its Phase 3 HERO pivotal clinical trial assessing ARD-101 for the t...